• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » Coalition urges Hamburg, FDA to hasten UDI adoption

Coalition urges Hamburg, FDA to hasten UDI adoption

July 12, 2010 By MassDevice staff

APS logo

The Advancing Patient Safety Coalition is urging Dr. Margaret Hamburg, head of the Food & Drug Administration, to immediately issue a proposed rule establishing a so-called "unique device identification" system for medical devices.

The coalition, comprised of 25 prominent medical associations including the American Health Assn., the American Nurses Assn. and several specialists’ associations, calling it a "critical" issue for patient safety, the implementation of electronic medical records and healthcare reform.

In a July 7 letter (PDF) to Hamburg, the coalition wrote that the FDA has been too slow in issuing a rule on the UDI system, which Congress approved in 2006.

"While the Coalition recognizes and appreciates the work and interest of the FDA on UDI,
it is taking the agency an unreasonable amount of time to publish a proposed rule," according to the letter. "With each
day that elapses without a UDI system in place, patients’ lives are put at needless risk."

The system would increase patient safety by creating a means of tracking medical devices — a capability that doesn’t exist today, according to the letter. Citing recall and “device correction” statistics, the coalition wrote that “providers often must use manual and imprecise systems to identify if they have any recalled products.”

The UDI system is also "essential" to the $20 billion push for EMR adoption contained in the American Recovery & Reinvestment Act, according to the letter, because EMR systems "require that data standards, including
those for medical devices, are in place and used by all institutions to transfer information.
Having a UDI system for medical devices is a basic requirement that must be in place before
automated identification systems are fully effective."

And adoption of a UDI system would increase efficiencies in the healthcare supply chain that could potentially save $16 billion a year "because providers will be able to track
recalled products more accurately and improve the quality, safety and affordability of care they
provide their patients," according to the coalition.

Here’s the full text of the letter:

Dear Commissioner Hamburg:

As members of the Advancing Patient Safety Coalition, we write to urge the Food and Drug Administration (FDA) to issue a proposed rule immediately that establishes a unique device identification (UDI) system that supports both national and global needs through the GS1 system. The Coalition membership, which includes prominent hospital, physician, nursing, research, quality and patient advocacy organizations, believes the proposed rule must be published now as UDI is critical to patient safety improvement initiatives as well as implementing electronic health records (EHRs) and the delivery system reforms included in the recently enacted health reform bill. Additionally, the efficiencies gained through UDI will save the healthcare system billions of dollars, which providers could reinvest in initiatives to improve the quality and safety of care.

While the Coalition recognizes and appreciates the work and interest of the FDA on UDI,
it is taking the agency an unreasonable amount of time to publish a proposed rule. As you
know, it has been three years since Congress passed the “The Food and Drug Administration
Amendments Act of 2007,” which included language requiring the FDA to promulgate
regulations establishing a national UDI system for medical devices. Moreover, the FDA
has been working on this issue for years before the legislation was passed. With each
day that elapses without a UDI system in place, patients’ lives are put at needless risk.

Improving patient safety:

Unlike medications, and virtually every other product in commerce, medical devices cannot
be identified in a systematic and consistent manner. The resulting ad hoc approach results
in increased clinical risks to patients. These clinical risks include implanting a defective,
counterfeit, or recalled product; inability to track the recipient of a faulty product if it is recalled;
and inability to appropriately track adverse events. UDI is the missing link to protect the safety
of patients by improving processes for device recalls and corrections.

The rapidly rising number of device recalls points to the need for UDI for effective management.
More than 700 medical device recalls were issued in 2008, including more than 100 Class 1
recalls (defined as dangerous or defective products that predictably could cause serious health
problems or death). Manufacturers also issue many “device corrections” that can have serious
consequences for patients if not handled correctly. Because of the absence of UDI, providers
often must use manual and imprecise systems to identify if they have any recalled products.

Realizing the value of EHRs and goals of health reform:

Since the FDA Amendments Act of 2007 was passed, Congress has also enacted stimulus
legislation that included over $20 billion to incentivize providers to adopt EHRs. UDI is
essential to maximizing the value of EHRs. The EHR will require that data standards, including
those for medical devices, are in place and used by all institutions to transfer information.
Having a UDI system for medical devices is a basic requirement that must be in place before
automated identification systems are fully effective.

The Patient Protection and Affordable Care Act (PPACA) signed into law this spring included
numerous quality improvement provisions and payment delivery system reforms that encourage
collaboration among providers. These initiatives, such as accountable care organizations
(ACOs), depend on providers working together to improve the overall health status of defined
populations of patients. Technology will be an important part of this collaboration, but the data
being shared on medical devices must be accurate and dependable.

Realizing efficiencies:

UDI will also greatly benefit the U.S. healthcare supply chain through increased efficiencies and
improved order accuracy, which will result in substantial savings. Patients will be the ultimate
beneficiaries of a more efficient supply chain system because providers will be able to track
recalled products more accurately and improve the quality, safety and affordability of care they
provide their patients.

In 1996, the Efficient Healthcare Consumer Response (EHCR) released a study
entitled “Improving the Efficiency of the Healthcare Supply Chain” stating that $11 billion
of supply chain costs each year are avoidable process costs, which could be saved through
improved efficiencies. These savings were tied to the adoption of a healthcare identifier,
universal product number, identification standards and electronic data interchange and bar
coding. This study was recently updated by Arizona State researchers and now estimates supply
chain savings at a total of $16 billion annually.

Additionally, a 2009 comprehensive survey entitled “The State of Healthcare Logistics”
conducted by researchers at the University of Arkansas found that the average healthcare
provider spends more than $72 million a year on supply-chain functions, which is nearly one-third
of their annual operating budget. UDI is key to the ability of providers to lower their supply
costs.

In closing, we again thank you for the work of the FDA on this important issue and reiterate we
cannot wait any longer. A regulated, mandatory UDI system that is globally harmonized will
ultimately improve patient safety, reduce medical errors, facilitate device recalls, improve device
adverse event reporting and recognize the full potential of EHRs and delivery system reforms.

Sincerely,

Alliance for Advancing Nonprofit Health Care
American Academy of Orthopaedic Surgeons

American Gastroenterological Assn.

American Hospital Assn.

American Medical Student Assn.

American Nurses Assn.

American Urological Assn.

Assn. for Healthcare Resources and Materials Management

Assn. for Professionals in Infection Control and Epidemiology

Catholic Health Assn. of the United States

National Assn. for Continence

Novation

PeaceHealth

Premier

Society for Cardiovascular Angiography and Interventions

Society for Healthcare Epidemiology of America

Texas Health Resources

The Hip Society

The National Assn. of Public Hospitals and Health Systems

The North American Spine Society

University HealthSystem Consortium

VHA Inc.

West Penn Allegheny Health System

West Virginia United Health System

White River Medical Center

Filed Under: Business/Financial News, News Well Tagged With: Advancing Patient Safety Coalition, Gift Bans

In case you missed it

  • Abbott will spend $450M to up FreeStyle Libre production in Ireland
  • Acutus Medical ticks up on revenue beat, missed EPS in Q2 results
  • ResMed expects steady growth over the next year
  • Ambu is letting go of 200 employees
  • Medtronic has Class I recall for low-shock risk in ICDs
  • Titan Medical to start manufacturing Enos systems later this year
  • ZimVie sales down more than 11% in Q2 as it streamlines after spinoff
  • Cardinal Health’s CFO to move up to corner office
  • Levita Magnetics raises $26M for Magnetic-Assisted Robotic Surgery platform
  • Data supports use of Channel Medsystems Cerene cryotherapy
  • The 10 largest orthopedic device companies in the world
  • Nanopath raises $10M Series A for women’s health diagnostics
  • Avenda wins FDA IDE nod for AI-enabled prostate cancer therapy
  • NuVasive chief commercial officer Massimo Calafiore is stepping down
  • Preparing your medical device company for challenging market conditions
  • Dentsply Sirona replaces chief accounting officer amid internal investigation
  • Haemonetics stock rises on Street-beating Q1, raised guidance

RSS From Medical Design & Outsourcing

  • The 24 best medical device innovations of 2022
    The Galien Foundation recently announced its nominees of medical device innovations for its 2022 Prix Galien USA awards. There are 24 medical technologies nominated for the annual award this year, up from 18 nominees in 2021. The Galien Foundation’s annual Prix Galien awards highlight devices, biotechnology and pharmaceutical products designed to improve the human condition.… […]
  • FDA issues new COVID-19 testing guidance to avoid false negatives
    COVID-19 testing should be repeated following a negative result on any antigen test, the FDA said in a move that could increase demand for diagnostics manufacturers. The latest guidance from the federal health agency is for negative COVID-19 antigen test results regardless of the presence or absence of symptoms. The federal agency said recent studies… […]
  • Confluent Medical expands Costa Rica manufacturing footprint for nitinol, complex catheter production
    Confluent Medical Technologies this week announced the opening of its new addition to its Costa Rica manufacturing facility. The expansion adds 66,000 sq. ft to its large-scale manufacturing center of excellence in Alajuela, Costa Rica to expand Confluent’s capacity for nitinol component processing and complex catheter manufacturing. “Confluent has experienced consistent and strong growth in… […]
  • FDA’s breakthrough medical device designations tally nears 700
    Stewart Eisenhart, Emergo Group The US Food and Drug Administration has granted almost 700 designations over the past seven years under a voluntary program for expedited regulatory review of medical devices and combination products that facilitate more effective treatment or diagnosis of serious diseases. According to recent metrics published by FDA, the agency has issued a total of… […]
  • Lifecore Biomedical’s owner plans to go all-in on contract development and manufacturing
    Lifecore Biomedical parent company Landec Corp. (Nasdaq:LNDC) plans to take the subsidiary’s name, leadership and headquarters as its own and sell off food businesses to focus on contract development and manufacturing. Santa Maria, California-based Landec said it will rename itself as Lifecore Biomedical “in the near future” and change its Nasdaq ticker to LFCR. Landec… […]
  • COVID-19 immunity test developers at MIT seek diagnostic manufacturer
    MIT researchers have developed a device for predicting an individual’s COVID-19 immunity and are looking for a diagnostic company to get it manufactured in large numbers and approved by the FDA. The lateral flow test uses the same technology as at-home rapid antigen COVID-19 tests to measure neutralizing antibodies for SARS-CoV-2 in a blood sample,… […]
  • GE Healthcare picks AI imaging startups for inaugural Edison Accelerator
    GE Healthcare and Nex Cubed have selected seven companies focused on artificial-intelligence-augmented medical imaging for the first cohort of the Edison Accelerator in Canada. The companies will be matched with mentors and test their technologies with GE’s new Edison Digital Health Platform over the next three months. The program will end with innovation showcase presentations… […]
  • Boston Scientific whistleblower launches corruption investigation
    Boston Scientific (NYSE:BSX) is investigating claims that the company violated the U.S. Foreign Corrupt Practices Act in Vietnam. Marlborough, Massachusetts–based Boston Scientific disclosed receipt of a whistleblower’s allegations in its latest filing with the Securities and Exchange Commission. “In March 2022, the company received a whistleblower letter alleging Foreign Corrupt Practices Act violations in Vietnam.… […]
  • 5 essential leadership lessons from Cathy Burzik for medtech’s next generation of women leaders
    Cathy Burzik, a seasoned senior executive in the healthcare industry, has successfully led major medical device, diagnostic, diagnostic imaging and life sciences businesses. Cathy Burzik, CFB Interests (as told to MedExecWomen co-founder Maria Shepherd) One key to being a successful women leader in MedTech: “Play nice, but play to win.” Cathy Burzik, who received a… […]
  • Stratasys plans to buy Covestro’s additive manufacturing business
    Stratasys (Nasdaq:SSYS) said today that it has a deal to purchase the additive manufacturing materials business of Covestro. The deal includes R&D facilities and activities, global development and sales teams across Europe, the U.S. and China, a portfolio of approximately 60 additive manufacturing materials, and hundreds of patents and patents pending, Stratasys said in a… […]
  • New implant design prevents scar tissue without drugs, MIT says
    Mechanically inflating and deflating an implantable device for 10 minutes a day prevents immune cells from building the scar tissue that has been a major obstacle for artificial pancreas researchers. That’s according to new findings from a team of MIT engineers who built mechanical deflection into a two-chambered, soft polyurethane device tested on mice. By… […]

Leave a Reply

You must be logged in to post a comment.

Primary Sidebar

DeviceTalks Weekly

August 12, 2022
DTW – Medtronic’s Mauri brings years of patient care to top clinical, regulatory, scientific post
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy